You are here: Industry Insights > HHS

News List

U.S. Buys 600,000 Doses of New COVID-19 Treatment Still Awaiting FDA Approval drugs.com
February 11, 2022
The U.S. government has bought 600,000 doses of a new antibody drug called bebtelovimab that seems able to beat back the omicron...
Mathematica and HHS Technology Group to Deliver Claims and Clinical Data Analytics Platform prnewswire
January 28, 2022
HHS Technology Group, LLC™ (HTG) announced today that it is collaborating with Mathematica, a market leader and insight partner in health care analytics and services...
Watchdog says key federal health agency is failing on crises FirstWordPharma
January 28, 2022
The US Government Accountability Office (GAO) said it is designating the Health and Human Services (HHS) department's leadership and coordination of public health emergencies as a "high risk" area for the government...
Biden Administration to support resilience of US pharma supply chain europeanpharmaceuticalreview
August 03, 2021
US President announces $60 million in funding to support domestic API production and a consortium to onshore essential medicine manufacturing.
Affinity Empowering Launches Website to Facilitate Enrollment into Fully Funded COVID-19 Test Program prnewswire
June 24, 2021
Affinity Empowering, Inc today announced the launch of affinitytesting, a new website designed to facilitate the enrollment of K-12 schools and community organizations into fully funded COVID-19 testing surveillance programs.
HHS Launches First Venture Capital Partnership to Develop Transformative Technologies to Combat Future Pandemics, Other Health Emergencies firstwordpharma
June 04, 2021
The U.S. Department of Health and Human Services (HHS) today unveiled a new type of public-private partnership that enables investments using venture capital practices.
Agreement builds on an earlier announcement that included support for the clinical development and supply of the treatment worldpharmanews
March 22, 2021
AstraZeneca has modified an existing agreement with the US Government to supply up to 500,000 additional doses of AZD7442, a long-acting antibody (LAAB) combination which is in late-stage development for the prevention and treatment of COVID-19.
CONTINUUS Awarded $69.3M DoD Grant contractpharma
January 25, 2021
CONTINUUS Pharmaceuticals Inc. received a $69.3 million U.S. government contract to facilitate domestic production of three vital medicines used to treat critically ill patients, including COVID-19.
US pharma initiates litigation challenging HHS and FDA action europeanpharmaceuticalreview
November 26, 2020
PhRMA and other organisations have challenged action by the HHS and FDA that permits the importation of drugs from Canada without drug manufacturers’ oversight.
HHS Funds Development of Needle-free Vax Technology contractpharma
October 10, 2020
Patch could administer vaccines without traditional needles reducing the need for refrigeration in transport and storage, and possibly self-administration.

Previous page 1 2 3 Next page